Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome
- PMID: 10527680
- DOI: 10.1006/mgme.1999.2927
Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome
Abstract
Chediak-Higashi syndrome (CHS) is a rare autosomal recessive disorder characterized by variable degrees of oculocutaneous albinism, easy bruisability, and bleeding as a result of deficient platelet dense bodies, and recurrent infections, with neutropenia, impaired chemotaxis and bactericidal activity, and abnormal NK cell function. Neurologic involvement is variable, but often includes peripheral neuropathy. Most patients also undergo an "accelerated phase," which is a nonmalignant lymphohistiocytic infiltration of multiple organs resembling lymphoma. Death often occurs in the first decade from infection, bleeding, or development of the accelerated phase. The hallmark of CHS is the presence of huge cytoplasmic granules in circulating granulocytes and many other cell types. These granules are peroxidase-positive and contain lysosomal enzymes, suggesting that they are giant lysosomes or, in the case of melanocytes, giant melanosomes. The underlying defect in CHS remains elusive, but the disorder can be considered a model for defects in vesicle formation, fusion, or trafficking. Because the beige mouse demonstrates many characteristics similar to those of human CHS patients, including dilution of coat color, recurrent infections, and the presence of giant granules, it is considered the animal homologue of CHS. The beige gene, Lyst, was mapped and sequenced in 1996, prompting identification of the human LYST gene on chromosome 1q42. Lyst and LYST show 86.5% sequence homology. LYST encodes a 429 kDa protein with a function that remains unknown, but the source of extensive speculation among students of cell biology.
Copyright 1999 Academic Press.
Similar articles
-
On the analysis of the pathophysiology of Chediak-Higashi syndrome. Defects expressed by cultured melanocytes.Lab Invest. 1994 Jul;71(1):25-34. Lab Invest. 1994. PMID: 8041115
-
Chediak-Higashi syndrome.Curr Opin Hematol. 2008 Jan;15(1):22-9. doi: 10.1097/MOH.0b013e3282f2bcce. Curr Opin Hematol. 2008. PMID: 18043242 Review.
-
Hermansky-Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking.Thromb Haemost. 2001 Jul;86(1):233-45. Thromb Haemost. 2001. PMID: 11487012 Review.
-
Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome.Nat Genet. 1996 Nov;14(3):307-11. doi: 10.1038/ng1196-307. Nat Genet. 1996. PMID: 8896560
-
Two novel CHS1 (LYST) mutations: clinical correlations in an infant with Chediak-Higashi syndrome.Mol Genet Metab. 2005 Jun;85(2):125-32. doi: 10.1016/j.ymgme.2005.02.011. Epub 2005 Mar 25. Mol Genet Metab. 2005. PMID: 15896657
Cited by
-
Mutational Analysis of the TYR and OCA2 Genes in Four Chinese Families with Oculocutaneous Albinism.PLoS One. 2015 Apr 28;10(4):e0125651. doi: 10.1371/journal.pone.0125651. eCollection 2015. PLoS One. 2015. PMID: 25919014 Free PMC article.
-
Molecular defects that affect platelet dense granules.Semin Thromb Hemost. 2004 Oct;30(5):537-47. doi: 10.1055/s-2004-835674. Semin Thromb Hemost. 2004. PMID: 15497096 Free PMC article. Review.
-
Lysosomal size matters.Traffic. 2020 Jan;21(1):60-75. doi: 10.1111/tra.12714. Epub 2019 Dec 6. Traffic. 2020. PMID: 31808235 Free PMC article. Review.
-
Deficiency in Lyst function leads to accumulation of secreted proteases and reduced retinal adhesion.PLoS One. 2022 Mar 3;17(3):e0254469. doi: 10.1371/journal.pone.0254469. eCollection 2022. PLoS One. 2022. PMID: 35239671 Free PMC article.
-
Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.Immunol Rev. 2019 Jan;287(1):202-225. doi: 10.1111/imr.12725. Immunol Rev. 2019. PMID: 30565241 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases